1.Used to detect the rearrangement status of the ETS-related gene (ERG) in prostate cancer patients.
ERG rearrangement status can serve as an independent predictor of metastasis.
2.It occurs primarily in prostate cancer, and some studies suggest that it is associated with poor prognosis and may guide the use of abiraterone therapy.